Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation.
作者信息
Devine Emily Beth, Perfetto Eleanor, Pickard A Simon, Schumock Glen T, Segal Jodi B, Cannon Eileen, Gagnon Jean Paul, Brixner Diana I, Garrison Louis P, Murray Michael D
机构信息
The Comparative Health Outcomes Policy & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA.
Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA.
出版信息
J Comp Eff Res. 2018 Feb;7(2):167-175. doi: 10.2217/cer-2017-0059. Epub 2018 Feb 21.
The term comparative effectiveness research (CER) took center stage with passage of the American Recovery and Reinvestment Act (2009). The companion US$1.1 billion in funding prompted the launch of initiatives to train the scientific workforce capable of conducting and using CER. Passage of the Patient Protection and Affordable Care Act (2010) focused these initiatives on patients, coining the term 'patient-centered outcomes research' (PCOR). Educational and training initiatives were soon launched. This report describes the initiative of the Pharmaceutical Research and Manufacturers Association of America (PhRMA) Foundation. Through provision of grant funding to six academic Centers of Excellence, to spearheading and sponsoring three national conferences, the PhRMA Foundation has made significant contributions to creation of the scientific workforce that conducts and uses CER/PCOR.
Zotero 插件